PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms
Dry Eye, Dry Eye Disease, Kerato Conjunctivitis Sicca
About this trial
This is an interventional treatment trial for Dry Eye
Eligibility Criteria
Inclusion Criteria: Patient Informed consent form (ICF) signed; Male and Female Aged ≥ 18 years at the time of the signature of the ICF; Patients with ocular symptoms such as burning, itching, and foreign body sensation due to environmental factors, contact lenses wearing, and/or moderate-severe dry eye symptoms; Willing not to use other eye drops during the entire treatment period. Exclusion Criteria: Other - different - eyes clinical conditions (e.g. glaucoma); Suspected alcohol or drug abuse. Known hypersensitivity or allergy to Investigational Product (IP) components; Other clinically significant and uncontrolled pathologies that may interfere with study results (e.g. rheumatic diseases, diabetes); Participation in another investigational study; Inability to follow all study procedures, including attending all site visits, tests and examinations; Mental incapacity that precludes adequate understanding or cooperation.
Sites / Locations
- Azienda Ospedaliera Policlinico Mater Domini - Università Magna Grecia di Catanzaro
Arms of the Study
Arm 1
Experimental
Eyedrops treatment arm